Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy; Phase 1/2 Study of RRMM Patients
![](https://i.ytimg.com/vi/-12e_UNEh20/maxresdefault.jpg)
![](https://imf-d8-prod.s3.us-west-1.wasabisys.com/styles/card/s3/2024-02/ash-asco-eha-research-general-header-template-paul-richardson-4762.jpg?itok=W9yQK8PD)
RVd Alone vs Rvd Plus ASCT in Newly Diagnosed Patients
![](https://assets.isu.pub/document-structure/230517214322-772530c85722ce48206c59f6f1cb23c1/v1/eb1b1a909ed731ab49c6d744bcfc4ba4.jpeg)
IMF Patient & Family Webinar 2023 - Understanding The New Myeloma
![](https://i.ytimg.com/vi/b6oW1YUZauE/sddefault.jpg)
Results from the first-in-human study of Modakafusp Alfa in Pts
![](https://static.wixstatic.com/media/cd6738_e435f4977ad347689b8e3eaa267e828a~mv2.jpeg/v1/fill/w_280,h_210,fp_0.50_0.50,q_90,enc_auto/cd6738_e435f4977ad347689b8e3eaa267e828a~mv2.jpeg)
Myeloma Clinical Trials
![](https://i.ytimg.com/vi/-12e_UNEh20/maxresdefault.jpg)
Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy
Congress and Scientific Presentations at ash
![](https://www.myeloma.org/sites/default/files/video_thumbnails/6wt5SOv79_s.jpg)
ctDNA Analysis and Relapse Association in Primary RRMM Patients
![](https://europepmc.org/articles/PMC9775488/bin/cancers-14-06026-g002a.jpg)
Current Status of Novel Agents for the Treatment of B Cell
![](https://assets.isu.pub/document-structure/230517214322-772530c85722ce48206c59f6f1cb23c1/v1/e7f9b18f851ce9494de60ace252fe4d8.jpeg)
IMF Patient & Family Webinar 2023 - Understanding The New Myeloma
![](https://i.ytimg.com/vi/JurvGnwWu90/maxresdefault.jpg)
RVd Alone vs Rvd Plus ASCT in Newly Diagnosed Patients
![](https://cdn.sanity.io/images/0vv8moc6/targetedonc/6430d1492d2596bce776901b978ceb3070bf3807-914x1170.png?fit=crop&auto=format)
Interleukin-Based Treatments Find Footing in Ongoing Research
![](https://assets.isu.pub/document-structure/230517214322-772530c85722ce48206c59f6f1cb23c1/v1/e32831a306686a36ad8d5e422e850251.jpeg)
IMF Patient & Family Webinar 2023 - Understanding The New Myeloma
![](https://www.frontiersin.org/files/Articles/1147008/fneur-14-1147008-HTML/image_m/fneur-14-1147008-g001.jpg)
Frontiers Sustained response in early responders to safinamide